Table 1.
DCBLD1 expression in HNSCC patients with different clinical parameters.
| Characteristics | DCBLD1 mRNA expression | p | |
|---|---|---|---|
| Low (n = 250) | High (n = 250) | ||
| Age | 0.755 | ||
| ≤60 | 120 (24%) | 124 (24.8%) | |
| >60 | 130 (26.1%) | 125 (25.1%) | |
| T stage | 0.430 | ||
| T1 | 17 (3.5%) | 16 (3.3%) | |
| T2 | 80 (16.5%) | 63 (13%) | |
| T3 | 62 (12.8%) | 68 (14%) | |
| T4 | 85 (17.5%) | 94 (19.4%) | |
| N stage | 0.366 | ||
| N0 | 122 (25.5%) | 117 (24.5%) | |
| N1 | 35 (7.3%) | 45 (9.4%) | |
| N2 | 81 (16.9%) | 71 (14.9%) | |
| N3 | 2 (0.4%) | 5 (1%) | |
| M stage | 0.684 | ||
| M0 | 237 (49.9%) | 233 (49.1%) | |
| M1 | 2 (0.4%) | 3 (0.6%) | |
| Clinical stage | 0.637 | ||
| Stage I | 8 (1.6%) | 11 (2.3%) | |
| Stage II | 45 (9.3%) | 50 (10.3%) | |
| Stage III | 56 (11.5%) | 46 (9.5%) | |
| Stage IV | 136 (28%) | 134 (27.6%) | |
| Lymph node neck dissection | 0.025* | ||
| No | 55 (11.1%) | 35 (7%) | |
| Yes | 193 (38.8%) | 214 (43.1%) | |